New chemical stabilizers, vehicles and delivery systems to enhance efficacy of low strength anthralin formulations.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000008:administration & dosage*; D000875:Anthralin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014677:Pharmaceutical Vehicles; D011565:Psoriasis / Q000188:drug therapy
D000873:Anthracenes; D014677:Pharmaceutical Vehicles; D000875:Anthralin